Synergy Pharma (SGYP) Shares Slump Early; Allergan Interest Questioned
Get Alerts SGYP Hot Sheet
Join SI Premium – FREE
(Updated - August 24, 2016 9:51 AM EDT)
Synergy Pharma (Nasdaq: SGYP) shares are down early Wednesday. The stock is off around 5 percent with heavy volume at the start. Today's trading action follows a 3 percent drop on Tuesday.
UPDATE - on Mad Money Monday night, Jim Cramer commented:
I don't think that Brent Saunders [CEO of Allergan] is going to buy them ... Look, it's had a good run. It's almost doubled. I would say it's for speculation only. Remember, it can pull back. It's had such a big run.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shift4 CEO says bids from suitors did not adequately value the firm; shares down
- Alibaba (BABA) to take on Coupang (CPNG) with $1.1bn investment in South Korea - Nikkei
- Apple (AAPL) Buys DarwinAI in Bid to Add Features - Bloomberg
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and Acquisitions, Rumors, Trader TalkRelated Entities
Jim CramerSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!